News 5/21/25
Top News
Regeneron Pharmaceuticals acquires 23andMe’s Personal Genome Service, Total Health and Research Services businesses, and Biobank and related assets for $256 million at bankruptcy auction, beating out a bid from co-founder and former CEO…
Continue Reading